Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp Ads (NQ: AMRN )

5.790 USD -0.200 (-3.34%)
Official Closing Price Updated: 7:58 PM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Amarin Corp Ads

< Previous 1 2
...
34 35 36 37 38 39 40 41 Next >
UPDATE 1-FDA accepts marketing application of Amarin's heart pill
Nov 25 (Reuters) - Biopharmaceutical company Amarin Corp said U.S health regulators have accepted the marketing application for its heart pill AMR101 and set an eight-month review period. 
Tags companyNews
From Reuters: Company News
Lightning Round: Sanofi, InterLinks, Ford Motor and More
Cramer makes the call on viewers' favorite stocks. 
Tags Mad Money for Mobile Investing/Stock Market/Stock Picks Investing/Stock Market
From CNBC.com News
Look for Shares of Amarin to Potentially Rebound after Yesterday's 3.25% Sell Off (AMRN)
From Comtex SmarTrend® News Briefs
Gain In Service Sector Jobs Lifts Markets
Employment rose in the nation's service sector to lift the markets higher during the midday with the Dow soaring 181 points to 11,839. Nasdaq climbed 28 points to 2635. 
Tags Market News
From MarketMinute.com Market Updates
Amarin Continues Falling
Shares of Amarin Corp. (Nasdaq: AMRN) continued falling by dropping 97 cents to $8.02 after the Patent Office issued a non-final rejection of the company's lipid lowering medication AMR101 last... 
From MarketMinute.com Stock News
Gain In Service Sector Jobs Lifts Markets
Tags SIMO AMRN WMGI
From MarketMinute » Market Updates
Look for Shares of Amarin to Potentially Rebound after Yesterday's 4.36% Sell Off (AMRN)
From Comtex SmarTrend® News Briefs
After Yesterday's Decline of 3.49%, Amarin Offers Investors Better Value (AMRN)
From Comtex SmarTrend® News Briefs
Look for Shares of Amarin to Potentially Rebound after Yesterday's 3.00% Sell Off (AMRN)
From Comtex SmarTrend® News Briefs
36.2% Return Seen to Date on SmarTrend Amarin Call (AMRN)
From Comtex SmarTrend® News Briefs
SmarTrend Watching for Potential Rebound in Shares of Amarin After 2.26% Loss (AMRN)
From Comtex SmarTrend® News Briefs
Amarin Shares Down 26.3% Since SmarTrend Said Sell (AMRN)
From Comtex SmarTrend® News Briefs
Amarin Corp Announced Results Of Its Pivotal MARINE Phase 3 Clinical Trial Were Published In American Journal of Cardiology (AMRN)
From Comtex SmarTrend® News Briefs
Downtrend Call Realized As Amarin Stock Falls 27.8% (AMRN)
From Comtex SmarTrend® News Briefs
SmarTrend Watching for Potential Rebound in Shares of Amarin After 8.93% Loss (AMRN)
From Comtex SmarTrend® News Briefs
Thursday’s biggest gaining & declining stocks
MarketWatch’s daily rundown of shares making sizeable moves in the premarket. 
Tags Fiber Optics Biotechnology Mining and Metals
From MarketWatch
Amarin Down 26.4% Since SmarTrend Downtrend Call (AMRN)
From Comtex SmarTrend® News Briefs
Shares of Amarin are Moving Lower on 1.1x Above-Average Volume (AMRN)
From Comtex SmarTrend® News Briefs
Five Top Stock Picks for the Third Quarter: Analyst
As many companies are releasing their second-quarter earnings reports, one investment firm has released its list of top stock picks for the third quarter. David Kestenbaum, Morgan Joseph TriArtisan's... 
Tags Integra LifeSciences Corp Investing/Stock Market/Stock Picks Investing/Stock Market
From CNBC.com News
Amarin Has Returned 3.5% Since SmarTrend Recommendation (AMRN)
From Comtex SmarTrend® News Briefs
8.4% Return Seen to Date on SmarTrend Amarin Call (AMRN)
From Comtex SmarTrend® News Briefs
81.4% Return Seen to Date on SmarTrend Amarin Call (AMRN)
From Comtex SmarTrend® News Briefs
Lower Trading Range Below $15.78 Detected for Shares of Amarin (AMRN)
From Comtex SmarTrend® News Briefs
Amarin adds suppliers for "aggressive" drug launch
LONDON, May 31 (Reuters) - Amarin Corp Plc said on Tuesday it had signed contracts with new suppliers to make its heart pill AMR101 as it gears up for an "aggressive" launch of the experimental drug. 
Tags companyNews
From Reuters: Company News
SmarTrend Detects Potential Break Out In Shares of Amarin (AMRN)
From Comtex SmarTrend® News Briefs
Amarin Shares Up 126.3% Since SmarTrend's Buy Recommendation (AMRN)
From Comtex SmarTrend® News Briefs
Amarin Has Returned 113.1% Since SmarTrend Recommendation (AMRN)
From Comtex SmarTrend® News Briefs
Watch for Continued Gains in Shares of Amarin (AMRN)
From Comtex SmarTrend® News Briefs
SmarTrend Detects Amarin Falling Below 3-day Trading Range of $16.51 (AMRN)
From Comtex SmarTrend® News Briefs
Amarin Bullish Moving Average Crossover Alert (AMRN)
From Comtex SmarTrend® News Briefs
< Previous 1 2
...
34 35 36 37 38 39 40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.